Emmrich; Frank

Patent Applications and Registrations

Patent applications and USPTO patent grants for Emmrich; Frank.The latest application filed is for "prevention of graft rejection by prior use of modified grafts".

Company Profile

3.7.11

Emmrich; Frank - Leipzig DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti CD4 antibodies to prevent in particular graft-versus-host-disease (GVHD) Grant 10,577,588 - Fricke , et al.	2020-03-03
Prevention Of Graft Rejection By Prior Use Of Modified Grafts App 20190262396 - Emmrich; Frank ; et al.	2019-08-29
Anti CD4 antibodies to prevent in particular graft-versus-host-disease (GvHD) Grant 10,227,564 - Fricke , et al.	2019-03-12
Anti Cd4 Antibodies To Prevent In Particular Graft -versus - Host - Disease (gvhd) App 20180051254 - FRICKE; Stephan ; et al.	2018-02-22
Anti Cd4 Antibodies To Prevent In Particular Graft -versus - Host - Disease (gvhd) App 20180030414 - FRICKE; Stephan ; et al.	2018-02-01
Anti CD4 antibodies to prevent in particular graft-versus-host-disease (GvHD) Grant 9,745,552 - Fricke , et al. August 29, 2	2017-08-29
Clay mineral for reducing inorganic phosphates, in particular in renal replacement therapy Grant 9,585,913 - Mitzner , et al. March 7, 2	2017-03-07
Clay Mineral for Reducing Inorganic Phosphates, In Particular In Renal Replacement Therapy App 20150258138 - Mitzner; Steffen ; et al.	2015-09-17
Animal model for the human immune system, and method for producing the same Grant 8,986,743 - Emmrich , et al. March 24, 2	2015-03-24
Anti Cd4 Antibodies To Prevent In Particular Graft-versus-host-disease (gvhd) App 20130330334 - Fricke; Stephan ; et al.	2013-12-12
Methods of Using Labeled Ligands Having Human CD4 Specificity App 20110300069 - Emmrich; Frank ; et al.	2011-12-08
Animal Model for the Human Immune System, and Method for Producing the Same App 20080216182 - Emmrich; Frank ; et al.	2008-09-04
Use of a labeled ligand having human cd4 specificity for producing a diagnostic used in the analysis of migration and/or distribution patterns of cell populations App 20050124005 - Emmrich, Frank ; et al.	2005-06-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.